Systemic chemotherapy following non-curative resection may increase survival for people with gall bladder carcinoma, but not carcinomas of the pancreas, bile duct or ampulla of Vater

Affiliations

¹ Division of Gastroenterological Surgery, Department of Surgery, Shinshu University School of Medicine, Mastumoto, Japan. hanayan@hsp.md.shinshu-u.ac.jp <hanayan@hsp.md.shinshu-u.ac.jp>

Comment

Kazuhiro Hanazaki. Cancer Treat Rev. 2003 Apr.

. 2003 Apr;29(2):135-7.

doi: 10.1016/s0305-7372(03)00015-x.

¹ Division of Gastroenterological Surgery, Department of Surgery, Shinshu University School of Medicine, Mastumoto, Japan. hanayan@hsp.md.shinshu-u.ac.jp <hanayan@hsp.md.shinshu-u.ac.jp>

No abstract available

Comment on

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.
Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T; Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract. Takada T, et al. Cancer. 2002 Oct 15;95(8):1685-95. doi: 10.1002/cncr.10831. Cancer. 2002. PMID: 12365016 Clinical Trial.